Prior Intimation of Board Meeting

REMUS PHARMACEUTICALS LIMITED

General Information

NSE Symbol*		REMUS
Whether Company is SME*		Yes
ISIN*		INE0O5T01011
Type of Meeting		Board Meeting
Details of Committee Meeting or Other Type of Meeting
Type of Intimation*		New
Reason for Re-schedule (postpone or prepone) / Cancellation
Proposed Meeting Date		20-05-2026
Original Meeting Date
Whether trading window is closed*		Yes
Trading Window Closure- Start date		01-04-2026
Details of Trading Window Closure End date		22-05-2026
Date of Report		13-05-2026

Agenda*	1	Financial results
	2	Dividend
	3	Other business
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone And Consolidated
Period end Type		Yearly
Period up to (Month)		March
Period up to (Year)		2026
Mode of raising Funds
Type of Dividend		Final
Remarks (website dissemination)		Further, in this connection, please refer our earlier intimation dated March 27, 2026, whereby, pursuant to the Company's Code of Conduct framed in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended ("the Code"), the Trading Window for dealing in securities of the Company, for persons specified under the Code, was closed from April 01, 2026 till 48 hours after the Audited Standalone and Consolidated Financial Results of the Company for the half year and financial year March 31, 2026 are approved by the Board of Directors and submitted to the Stock Exchange.